A detailed history of Bessemer Group Inc transactions in Myriad Genetics Inc stock. As of the latest transaction made, Bessemer Group Inc holds 2,550 shares of MYGN stock, worth $34,807. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,550
Holding current value
$34,807
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$23.97 - $28.6 $61,123 - $72,930
2,550 New
2,550 $70,000
Q4 2023

Feb 09, 2024

BUY
$13.91 - $21.32 $1,877 - $2,878
135 New
135 $3,000
Q2 2023

Aug 10, 2023

BUY
$17.56 - $23.76 $1,194 - $1,615
68 New
68 $2,000
Q1 2021

May 13, 2021

BUY
$19.92 - $31.6 $7,928 - $12,576
398 New
398 $12,000
Q4 2018

Feb 12, 2019

SELL
$27.23 - $45.56 $1,361 - $2,278
-50 Closed
0 $0
Q3 2018

Nov 06, 2018

BUY
$37.57 - $50.34 $1,878 - $2,517
50 New
50 $2,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.1B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.